(1)
Silverberg, J.; Pink, A.; Olsen, C.; Weidinger, S. Use of Topical Corticosteroids With Tralokinumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial. J of Skin 2020, 4, s99.